Evaluating fermentation characteristics of Kazachstania spp. and their potential influence on wine quality

World Journal of Microbiology and Biotechnology - The current study is the first one to demonstrate the wine fermentation potential of members of several species of the genus Kazachstania including...     

An Integrated Approach to Thermoelectrics: Combining Phonon Dynamics,Nanoengineering, Novel Materials Development,Module Fabrication,and Metrology

This review discusses the longstanding efforts to develop advanced thermoelectrics through a multidisciplinary approach by combining condensed matter physics, nanotechnology, solid‐state chemistry, electrical engineering, mechanical engineering, and metrology. The phonon dynamics of skutterudites, clathrates, tetrahedrites, and layered LaOBiSSe are investigated through inelastic neutron scattering, allowing insights into their low lattice thermal conductivity due to rattling in a cage as well as under planar coordination. The electrical resistivity, Seebeck coefficient, and Hall coefficient of Bi‐nanowires are successfully measured with a home‐made system, demonstrating a size effect in thermoelectric and galvanomagnetic phenomena. For PbTe‐based bulk thermoelectrics, an exceptionally high figure of merit ZT (≈1.8 at 800 K) is achieved through nanostructuring. Moreover, correspondingly high conversion efficiency (≈11% for a temperature difference of 590 K) is demonstrated in nanostructured PbTe‐based modules. Sulfides (tetrahedrite, colusite, and CdI₂‐type layered systems) and arsenides (LnFeAsO and BaZn₂As₂) are developed as environmentally friendly and emerging thermoelectric materials, respectively. The output power and efficiency of modules with novel materials, including nanostructured PbTe, Zn₄Sb₃, and clathrates, are measured with the highly accurate self‐made system. Future opportunities and challenges for the widespread use of thermoelectric waste heat recovery and energy harvesting are also discussed.     

Genetic Variation at the BDNF Locus: Evidence for Association with Long-Term Outcome after Ischemic Stroke

Background and Purpose

Rates and extent of recovery after stroke vary considerably between individuals and genetic factors are thought to contribute to post-stroke outcome. Brain-derived neurotrophic factor (BDNF) plays important roles in brain plasticity and repair and has been shown to be involved in stroke severity, recovery, and outcome in animal models. Few clinical studies on BDNF genotypes in relation to ischemic stroke have been performed. The aims of the present study are therefore to investigate whether genetic variation at the BDNF locus is associated with initial stroke severity, recovery and/or short-term and long-term functional outcome after ischemic stroke.

Methods

Four BDNF tagSNPs were analyzed in the Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS; 600 patients and 600 controls, all aged 18–70 years). Stroke severity was assessed using the NIH Stroke Scale (NIHSS). Stroke recovery was defined as the change in NIHSS over a 3-month period. Short- and long-term functional outcome post-stroke was assessed using the modified Rankin Scale at 3 months and at 2 and 7 years after stroke, respectively.

Results

No SNP was associated with stroke severity or recovery at 3 months and no SNP had an impact on short-term outcome. However, rs11030119 was independently associated with poor functional outcome 7-years after stroke (OR 0.66, 95% CI 0.46–0.92; P =  0.006).

Conclusions

BDNF gene variants were not major contributors to ischemic stroke severity, recovery, or short-term functional outcome. However, this study suggests that variants in the BDNF gene may contribute to poor long-term functional outcome after ischemic stroke.     

Cardioembolic and Small Vessel Disease Stroke Show Differences in Associations between Systemic C3 Levels and Outcome

Background

Activation of the complement system has been proposed to play a role in the pathophysiology of stroke. As the specific involvement of the complement proteins may be influenced by stroke etiology, we compared plasma C3 and C3a levels in patients with cardioembolic (CE) and small vessel disease (SVD) subtypes of ischemic stroke and control subjects and evaluated their association to outcome at three months and two years.

Methodology/Principal Findings

Plasma C3 and C3a levels in 79 CE and 79 SVD stroke patients, sampled within 10 days and at three months after stroke, and age- and sex-matched control subjects from The Sahlgrenska Academy Study on Ischemic Stroke were measured by ELISA. Functional outcome was assesed with modified Rankin Scale. In the CE group, plasma C3 levels were elevated only in the acute phase, whereas C3a was elevated at both time points. The follow-up phase plasma C3 levels in the upper third were associated with an increased risk of unfavorable outcome at three months (OR 7.12, CI 1.72–29.46, P = 0.007) as well as after two years (OR 8.25, CI 1.61–42.28, P = 0.011) after stroke. These associations withstand adjustment for age and sex. Conversely, three-month follow-up plasma C3a/C3 level ratios in the middle third were associated with favorable outcome after two years both in the univariate analysis (OR 0.19, CI 0.05–0.82, P = 0.026) and after adjustment for age and sex (OR 0.19, CI 0.04–0.88, P = 0.033). In the SVD group, plasma C3 and C3a levels were elevated at both time points but showed no significant associations with outcome.

Conclusions

Plasma C3 and C3a levels are elevated after CE and SVD stroke but show associations with outcome only in CE stroke.